Evidence map›Paper›PMID 37082595›Full record

ArticleBBA advances2022

APP deficiency and HTRA2 modulates PrP

Denis S F Biard, Rafika Jarray, Nicolas Rebergue, François Leteurtre, Dulce Papy-Garcia

Open access · goldAbstract read
In one paragraph

Article in BBA advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Denis S F BiardCEA. Institut de Biologie François Jacob (IBFJ), SEPIA, Université Paris-Saclay, F-92265 Fontenay-aux-Roses, France.
Rafika JarrayCEA. Institut de Biologie François Jacob (IBFJ), SEPIA, Université Paris-Saclay, F-92265 Fontenay-aux-Roses, France.
Nicolas RebergueUniversité Paris Est Créteil (UPEC), Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), F-94010 Creteil, France.
François LeteurtreCEA. Institut de Biologie François Jacob (IBFJ), SREIT, Laboratoire de Cancérologie Expérimentale Université Paris-Saclay, F-92265 Fontenay-aux-Roses, France.
Dulce Papy-GarciaUniversité Paris Est Créteil (UPEC), Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), F-94010 Creteil, France.
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRUniversité Paris-Est Créteil · FRDirection de la Recherche Fondamentale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular protein homeostasis (proteostasis) requires an accurate balance between protein biosynthesis, folding, and degradation, and its instability is causally related to human diseases and cancers. Here, we created numerous engineered cancer cell lines targeting APP (amyloid ß precursor protein) and/or PRNP (cellular prion) genes and we showed that APP knocking-down impaired PRNP mRNA level and vice versa, suggesting a link between their gene regulation. PRNP

Indexed as

APPcancer cellsCD24CRISPR-Cas9HTRA2pEBVsiRNAPRNPproteostasisPrPcRNA interference

Identifiers

PMID37082595
PMCPMC10074928
OpenAlexW4200163788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.